Marco Studer
Chief Operating Officer at Aebi & Co. AG Maschinenfabrik
Network origin in Marco Studer first degree
Entity | Entity type | Industry | |
---|---|---|---|
Aviation Works Ltd.
Aviation Works Ltd. Miscellaneous Commercial ServicesCommercial Services Aviation Works Ltd. is a British company founded in 2018 that is inspired by aviation and medical research. The company's first product, Cordillera, is an update to the aircraft passenger emergency oxygen system and has received industry recognition.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Marco Studer via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Morgan Stanley & Co. International Plc
Morgan Stanley & Co. International Plc Investment Banks/BrokersFinance Morgan Stanley & Co. International Plc (MSCI) is a brokerage firm headquartered in London, UK. The firm was founded in 1986 and is a subsidiary of Morgan Stanley Investments (UK), ultimately held by Morgan Stanley (NYSE: MS) in the US. MSCI provides a range of brokerage services to corporations, governments and financial institutions. | Investment Banks/Brokers | Analyst-Equity | |
IIG Istanbul Investment Group
IIG Istanbul Investment Group Investment ManagersFinance IIG Istanbul Investment Group (IIG) is an independent private equity firm with headquarters in Istanbul, Turkey. The firm was founded in2015. | Investment Managers | President | |
Spiden AG
Spiden AG Miscellaneous Commercial ServicesCommercial Services Spiden AG is a company based in Pfaffikon, Switzerland that aims to become the benchmark platform for longevity and preventative medicine. The Swiss company provides real-time biomarker and drug analysis to empower clinicians, patients, and healthy individuals in making more informed and timely decisions, and increase the safety and efficacy of medical treatments. Spiden has developed the world's first data generation platform to perform spectroscopic measurements of a wide range of biomarkers and drugs in blood. The company envisions a future where human blood can be continuously measured with an implant and become state-of-the-art to living a healthier and longer life, detecting diseases earlier, and helping to improve and personalize medical treatments. In the short term, Spiden intends to work with established industry players and create blood monitoring technology that can improve the safety and efficacy of treatments of the critically ill in clinical settings. The company was founded by Leo Grünstein and Ovunc Okyay in 2017, and Leo Grünstein has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder |
Statistics
International
United Kingdom | 2 |
Turkey | 2 |
Switzerland | 2 |
Sectoral
Finance | 3 |
Commercial Services | 2 |
Operational
Director/Board Member | 3 |
Analyst-Equity | 1 |
President | 1 |
Founder | 1 |
Most connected contacts
Insiders | |
---|---|
Ovunc Okyay | 4 |
Robert Andrew Boyle | 1 |
Timothy Wakeford | 1 |
- Stock Market
- Insiders
- Marco Studer
- Company connections